Volcano Corporation Reports Fourth Quarter Revenues Increase Six Percent On A Constant Currency Basis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Feb. 24, 2014 -- /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the fourth quarter and all of 2013.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC